Velorum Therapeutics: A Biotech Model Targeting Heme Metabolism
A look at the business model of Velorum Therapeutics, a biotech company pursuing heme-targeting approaches in cancer and porphyria, based on an earlier Think & Rich article; its figures and events are unverified.
Think & Rich